XML 42 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Nov. 30, 2023
Nov. 30, 2022
Nov. 30, 2021
Dec. 01, 2020
Nov. 30, 2020
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Pay Versus Performance Table
The following table provides information regarding compensation paid to the PEO and the average of the Non-PEO NEOs, along with the cumulative TSR of the Company and a peer group index, the Company’s net income, and the Company Selected Measure, non-GAAP net income.
Value of Initial Fixed $100 Investment Based On: (In Millions)
Year(1)
Summary Compensation Table Total for PEO 1(2)
($)
Summary Compensation Table Total for PEO 2(2)
($)
Compensation Actually Paid to PEO 1(3)
($)
Compensation Actually Paid to PEO 2(3)
($)
Average Summary Compensation Table Total for Non-PEO NEOs(2)
($)
 Average Compensation Actually Paid to Non-PEO NEOs(3)
($)
 Total Shareholder Return(4)
($)
Peer Group Total Shareholder Return(4)
($)
 Net Income(5)
($)
Company Selected Measure: Non-GAAP Net Income(6) 
($)
20239,254,634  n/a 8,193,274  n/a 2,817,204 2,526,184 130.68 86.03 626.9 1,053.6 
20227,498,195  n/a 8,456,768  n/a 3,121,580 2,909,564 133.63 85.51 651.6 1,147.9 
20219,529,362 16,704,037 9,334,615 23,273,315 4,709,006 7,450,077 133.45 108.24 395.1 595.7 
—————
(1)    NEOs included in these columns reflect the following:
YearPEOsNon-PEO NEOs
2023Rich Hume (PEO 1)Dennis Polk, Marshall Witt, Michael Urban, Patrick Zammit
2022Rich Hume (PEO 1)Dennis Polk, Marshall Witt, Michael Urban, Patrick Zammit
2021Rich Hume (PEO 1)Marshall Witt, Michael Urban, Patrick Zammit, Peter Larocque, Simon Leung
Dennis Polk (PEO 2)
(2)    Amounts reflect the table labeled “2023 Summary Compensation Table” for our NEOs for each corresponding year, as follows:
(i)    the total compensation reported in the 2023 Summary Compensation Table for the applicable year for PEO 1 and PEO 2, and
(ii)    the average of the total compensation reported in the 2023 Summary Compensation Table for the applicable year for the Non-PEO NEOs reported for the applicable year.
(3)    The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table above for each year, adjusted for exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values in the Summary Compensation Table are calculated in accordance with FASB ASC Topic 718, using the grant date fair value of stock and option awards granted during the year, whereas CAP represents the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or were vested or forfeited during the year.
 Year
Summary Compensation Table Total(a)
($)
(Minus) Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year(b)
($)
Plus Fair Value at Fiscal Year-End of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value of Outstanding and Unvested Stock Option and Stock Awards Granted in Prior Fiscal Years(c)
($)
Plus Fair Value at Vesting of Stock Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value as of Vesting Date of Stock Option and Stock Awards Granted in Prior Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year(c)
($)
(Minus) Fair Value as of Prior Fiscal Year-End of Stock Option and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year(c)
($)
 Equals Compensation Actually Paid
($)
PEO 1
20239,254,634 (5,759,614)5,677,045 (701,565)— (277,226)— 8,193,274 
20227,498,195 (4,349,941)5,409,421 11,252 — (112,159)— 8,456,768 
2021(d)
9,529,362 (3,639,900)3,445,153 — — — — 9,334,615 
PEO 2
2023 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2022 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2021(d)
16,704,037 (12,528,928)14,611,088 1,574,513 643,291 2,269,314 — 23,273,315 
Non-PEO NEOs (Average)
20232,817,204 (1,114,461)1,086,993 (301,906)— 38,354 — 2,526,184 
20223,121,580 (1,264,076)1,344,275 (110,432)— (181,782)— 2,909,564 
2021(d)
4,709,006 (2,716,425)4,132,599 375,500 187,951 761,446 — 7,450,077 
(a)    Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year for the PEOs. For Non-PEO NEOs, amounts shown represent averages.
(b)    Represents the grant date fair value of the stock options and stock awards granted during the indicated fiscal year, calculated in accordance with ASC 718 as reported on the Summary Compensation Table. See Note 5 “Share-Based Compensation” to the Audited Financial Statements included in our Form 10-K for the fiscal year ended November 30, 2023 for a discussion of the relevant assumptions used in calculating these amounts.
(c)    The fair values of unvested and outstanding equity awards to our NEOs were remeasured starting on November 30, 2020, and subsequently as of each vesting date of vested awards, and as of the end of each fiscal year for unvested awards during the indicated fiscal year. Fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value on the grant date under US GAAP. For stock awards subject to performance-based vesting conditions, fair value was calculated based on an estimate of the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year. For stock options, a Black-Scholes model was used to estimate the fair value as of the various measurement dates based on the same methodology as used to determine grant date fair value but using the closing stock price on the applicable revaluation date, as well as updated assumptions related to the expected term, expected volatility, risk-free interest rate and dividend yield.
(d)     On December 1, 2020, the Company completed the separation (the “Separation”) of its customer experience services business in a tax-free transaction for federal income tax purposes, which was accomplished by the distribution of one hundred percent of the outstanding common stock of Concentrix Corporation (“Concentrix”). SYNNEX stockholders received one share of Concentrix common stock for every share of SYNNEX common stock held at the close of business on the record date. Concentrix is now an independent public company trading under the symbol “CNXC” on the Nasdaq Stock Market. After the Separation, SYNNEX did not beneficially own any shares of Concentrix’ common stock. The closing stock price of SYNNEX common stock on November 30, 2020 was $160.31. As a result of the impacts of the Separation, the opening stock price of SYNNEX common stock on December 1, 2020 was $82.01. The Company has used the opening stock price on December 1, 2020 to calculate changes in fair value of equity awards in fiscal 2021 in order to provide a comparable basis of performance for the fair value measurements.
(4)    Cumulative total shareholder return (“TSR”) assumes an initial investment of $100 as of the market open on December 1, 2020, the beginning of fiscal year 2021, for the Company’s common stock as well as the common stock of companies in our peer group. Our peer group is measured by the Computer and Peripheral Equipment index, which is based on the Standard Industrial Classification Code 5045—Wholesale Computer and Computer Peripheral Equipment and Software. For 2021, the measurement period was one (1) year, for 2022, the measurement period was two (2) years, and for 2023, the measurement period was three (3) years.
(5)    Reflects “Net Income” in our consolidated statements of income included in our Annual Reports on Form 10-K for the applicable year.
(6)    While we use numerous financial and non-financial performance measures to evaluate performance under our compensation programs, non-GAAP net income is our Company Selected Measure, which is the financial performance measure that, in our assessment, represents the most important performance measure used to link CAP to NEOs to Company performance in 2023. For a reconciliation of non-GAAP net income to the most directly comparable GAAP financial measure, net income, refer to Appendix A of this Proxy Statement for the reconciliation of GAAP to non-GAAP net income. 		       
Named Executive Officers, Footnote
(1)    NEOs included in these columns reflect the following:
YearPEOsNon-PEO NEOs
2023Rich Hume (PEO 1)Dennis Polk, Marshall Witt, Michael Urban, Patrick Zammit
2022Rich Hume (PEO 1)Dennis Polk, Marshall Witt, Michael Urban, Patrick Zammit
2021Rich Hume (PEO 1)Marshall Witt, Michael Urban, Patrick Zammit, Peter Larocque, Simon Leung
Dennis Polk (PEO 2)
        
Peer Group Issuers, Footnote Cumulative total shareholder return (“TSR”) assumes an initial investment of $100 as of the market open on December 1, 2020, the beginning of fiscal year 2021, for the Company’s common stock as well as the common stock of companies in our peer group. Our peer group is measured by the Computer and Peripheral Equipment index, which is based on the Standard Industrial Classification Code 5045—Wholesale Computer and Computer Peripheral Equipment and Software. For 2021, the measurement period was one (1) year, for 2022, the measurement period was two (2) years, and for 2023, the measurement period was three (3) years.        
Adjustment To PEO Compensation, Footnote
(3)    The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table above for each year, adjusted for exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values in the Summary Compensation Table are calculated in accordance with FASB ASC Topic 718, using the grant date fair value of stock and option awards granted during the year, whereas CAP represents the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or were vested or forfeited during the year.
 Year
Summary Compensation Table Total(a)
($)
(Minus) Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year(b)
($)
Plus Fair Value at Fiscal Year-End of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value of Outstanding and Unvested Stock Option and Stock Awards Granted in Prior Fiscal Years(c)
($)
Plus Fair Value at Vesting of Stock Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value as of Vesting Date of Stock Option and Stock Awards Granted in Prior Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year(c)
($)
(Minus) Fair Value as of Prior Fiscal Year-End of Stock Option and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year(c)
($)
 Equals Compensation Actually Paid
($)
PEO 1
20239,254,634 (5,759,614)5,677,045 (701,565)— (277,226)— 8,193,274 
20227,498,195 (4,349,941)5,409,421 11,252 — (112,159)— 8,456,768 
2021(d)
9,529,362 (3,639,900)3,445,153 — — — — 9,334,615 
PEO 2
2023 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2022 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2021(d)
16,704,037 (12,528,928)14,611,088 1,574,513 643,291 2,269,314 — 23,273,315 
Non-PEO NEOs (Average)
20232,817,204 (1,114,461)1,086,993 (301,906)— 38,354 — 2,526,184 
20223,121,580 (1,264,076)1,344,275 (110,432)— (181,782)— 2,909,564 
2021(d)
4,709,006 (2,716,425)4,132,599 375,500 187,951 761,446 — 7,450,077 
(a)    Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year for the PEOs. For Non-PEO NEOs, amounts shown represent averages.
(b)    Represents the grant date fair value of the stock options and stock awards granted during the indicated fiscal year, calculated in accordance with ASC 718 as reported on the Summary Compensation Table. See Note 5 “Share-Based Compensation” to the Audited Financial Statements included in our Form 10-K for the fiscal year ended November 30, 2023 for a discussion of the relevant assumptions used in calculating these amounts.
(c)    The fair values of unvested and outstanding equity awards to our NEOs were remeasured starting on November 30, 2020, and subsequently as of each vesting date of vested awards, and as of the end of each fiscal year for unvested awards during the indicated fiscal year. Fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value on the grant date under US GAAP. For stock awards subject to performance-based vesting conditions, fair value was calculated based on an estimate of the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year. For stock options, a Black-Scholes model was used to estimate the fair value as of the various measurement dates based on the same methodology as used to determine grant date fair value but using the closing stock price on the applicable revaluation date, as well as updated assumptions related to the expected term, expected volatility, risk-free interest rate and dividend yield.
(d)     On December 1, 2020, the Company completed the separation (the “Separation”) of its customer experience services business in a tax-free transaction for federal income tax purposes, which was accomplished by the distribution of one hundred percent of the outstanding common stock of Concentrix Corporation (“Concentrix”). SYNNEX stockholders received one share of Concentrix common stock for every share of SYNNEX common stock held at the close of business on the record date. Concentrix is now an independent public company trading under the symbol “CNXC” on the Nasdaq Stock Market. After the Separation, SYNNEX did not beneficially own any shares of Concentrix’ common stock. The closing stock price of SYNNEX common stock on November 30, 2020 was $160.31. As a result of the impacts of the Separation, the opening stock price of SYNNEX common stock on December 1, 2020 was $82.01. The Company has used the opening stock price on December 1, 2020 to calculate changes in fair value of equity awards in fiscal 2021 in order to provide a comparable basis of performance for the fair value measurements.
        
Non-PEO NEO Average Total Compensation Amount [1],[2] $ 2,817,204 $ 3,121,580 $ 4,709,006 [3]    
Non-PEO NEO Average Compensation Actually Paid Amount [4] $ 2,526,184 2,909,564 7,450,077 [3]    
Adjustment to Non-PEO NEO Compensation Footnote
(3)    The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table above for each year, adjusted for exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values in the Summary Compensation Table are calculated in accordance with FASB ASC Topic 718, using the grant date fair value of stock and option awards granted during the year, whereas CAP represents the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or were vested or forfeited during the year.
 Year
Summary Compensation Table Total(a)
($)
(Minus) Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year(b)
($)
Plus Fair Value at Fiscal Year-End of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value of Outstanding and Unvested Stock Option and Stock Awards Granted in Prior Fiscal Years(c)
($)
Plus Fair Value at Vesting of Stock Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value as of Vesting Date of Stock Option and Stock Awards Granted in Prior Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year(c)
($)
(Minus) Fair Value as of Prior Fiscal Year-End of Stock Option and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year(c)
($)
 Equals Compensation Actually Paid
($)
PEO 1
20239,254,634 (5,759,614)5,677,045 (701,565)— (277,226)— 8,193,274 
20227,498,195 (4,349,941)5,409,421 11,252 — (112,159)— 8,456,768 
2021(d)
9,529,362 (3,639,900)3,445,153 — — — — 9,334,615 
PEO 2
2023 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2022 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2021(d)
16,704,037 (12,528,928)14,611,088 1,574,513 643,291 2,269,314 — 23,273,315 
Non-PEO NEOs (Average)
20232,817,204 (1,114,461)1,086,993 (301,906)— 38,354 — 2,526,184 
20223,121,580 (1,264,076)1,344,275 (110,432)— (181,782)— 2,909,564 
2021(d)
4,709,006 (2,716,425)4,132,599 375,500 187,951 761,446 — 7,450,077 
(a)    Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year for the PEOs. For Non-PEO NEOs, amounts shown represent averages.
(b)    Represents the grant date fair value of the stock options and stock awards granted during the indicated fiscal year, calculated in accordance with ASC 718 as reported on the Summary Compensation Table. See Note 5 “Share-Based Compensation” to the Audited Financial Statements included in our Form 10-K for the fiscal year ended November 30, 2023 for a discussion of the relevant assumptions used in calculating these amounts.
(c)    The fair values of unvested and outstanding equity awards to our NEOs were remeasured starting on November 30, 2020, and subsequently as of each vesting date of vested awards, and as of the end of each fiscal year for unvested awards during the indicated fiscal year. Fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value on the grant date under US GAAP. For stock awards subject to performance-based vesting conditions, fair value was calculated based on an estimate of the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year. For stock options, a Black-Scholes model was used to estimate the fair value as of the various measurement dates based on the same methodology as used to determine grant date fair value but using the closing stock price on the applicable revaluation date, as well as updated assumptions related to the expected term, expected volatility, risk-free interest rate and dividend yield.
(d)     On December 1, 2020, the Company completed the separation (the “Separation”) of its customer experience services business in a tax-free transaction for federal income tax purposes, which was accomplished by the distribution of one hundred percent of the outstanding common stock of Concentrix Corporation (“Concentrix”). SYNNEX stockholders received one share of Concentrix common stock for every share of SYNNEX common stock held at the close of business on the record date. Concentrix is now an independent public company trading under the symbol “CNXC” on the Nasdaq Stock Market. After the Separation, SYNNEX did not beneficially own any shares of Concentrix’ common stock. The closing stock price of SYNNEX common stock on November 30, 2020 was $160.31. As a result of the impacts of the Separation, the opening stock price of SYNNEX common stock on December 1, 2020 was $82.01. The Company has used the opening stock price on December 1, 2020 to calculate changes in fair value of equity awards in fiscal 2021 in order to provide a comparable basis of performance for the fair value measurements.
        
Compensation Actually Paid vs. Total Shareholder Return Relationship Between NEO CAP, Company TSR, and Peer Group TSR
The following chart sets forth the relationship between CAP to our PEOs, the average of CAP to our Non-PEO NEOs, the Company’s cumulative TSR, and the Peer Group TSR.
1099511629477
        
Compensation Actually Paid vs. Net Income Relationship Between NEO CAP and Net Income 
The following chart sets forth the relationship between CAP to our PEO, the average of CAP to our Non-PEO NEOs, and our non-GAAP net income.
1099511629775
        
Compensation Actually Paid vs. Company Selected Measure Relationship Between NEO CAP and Non-GAAP Net Income (Company Selected Measure)
The following chart sets forth the relationship between CAP to our PEO, the average of CAP to our Non-PEO NEOs, and non-GAAP net income, our Company Selected Measure.
1099511631409
        
Tabular List, Table
Tabular List of Financial Performance Measures
The following table identifies the three most important financial performance measures used by the Compensation Committee to link the Compensation Actually Paid to our PEO and the average of other NEOs in 2023 to company performance. The role of each of these performance measures in our executive compensation programs is more thoroughly discussed in the “Executive Compensation” section in the CD&A along with a description of how executive compensation relates to Company performance and how the Compensation Committee makes its decisions.
Financial Performance Measures
Non-GAAP Net Income (1)
Adjusted Return on Invested Capital (ROIC)
Next Gen Contribution Margin
—————
(1)    Non-GAAP net income is a non-GAAP financial measure, which is considered to be the most important measure used by the Company to link compensation actually paid to our PEO and the average of Non-PEO NEOs to Company performance, also known as our Company Selected Measure. For a reconciliation of non-GAAP net income to the most directly comparable GAAP financial measure, net income, refer to Appendix A to this Proxy Statement.
        
Total Shareholder Return Amount [5] $ 130.68 133.63 133.45    
Peer Group Total Shareholder Return Amount [5] 86.03 85.51 108.24    
Net Income (Loss) [6] $ 626,900 $ 651,600 $ 395,100    
Company Selected Measure Amount [7] 1,053,600 1,147,900 595,700    
Closing Stock Price       $ 82.01 $ 160.31
Measure:: 1          
Pay vs Performance Disclosure          
Name [8] Non-GAAP Net Income (1)        
Measure:: 2          
Pay vs Performance Disclosure          
Name Adjusted Return on Invested Capital (ROIC)        
Measure:: 3          
Pay vs Performance Disclosure          
Name Next Gen Contribution Margin        
Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [9] $ (5,759,614)        
Rich Hume [Member]          
Pay vs Performance Disclosure          
PEO Total Compensation Amount [1],[2] 9,254,634 $ 7,498,195 $ 9,529,362 [3]    
PEO Actually Paid Compensation Amount [4] $ 8,193,274 8,456,768 9,334,615 [3]    
PEO Name Rich Hume (PEO 1)        
Rich Hume [Member] | Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [9]   (4,349,941) (3,639,900) [3]    
Rich Hume [Member] | Fair Value at Fiscal Year-End of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] $ 5,677,045 5,409,421 3,445,153 [3]    
Rich Hume [Member] | Change in Fair Value of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] (701,565) 11,252 0 [3]    
Rich Hume [Member] | Fair Value at Vesting of Stock Option and Stock Awards Granted in Fiscal Year tha tVested During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 0 [3]    
Rich Hume [Member] | Change in Fair Value as of Vesting Date of Stock Option and Stock Awards Granted in Prior Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] (277,226) (112,159) 0 [3]    
Rich Hume [Member] | Fair Value as of Prior Fiscal Year-End of Stock Option and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] $ 0 0 0 [3]    
Dennis Polk [Member]          
Pay vs Performance Disclosure          
PEO Total Compensation Amount [1],[2],[3]     16,704,037    
PEO Actually Paid Compensation Amount [3],[4]     23,273,315    
PEO Name Dennis Polk (PEO 2)        
Dennis Polk [Member] | Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [3],[9]     (12,528,928)    
Dennis Polk [Member] | Fair Value at Fiscal Year-End of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [3],[10]     14,611,088    
Dennis Polk [Member] | Change in Fair Value of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [3],[10]     1,574,513    
Dennis Polk [Member] | Fair Value at Vesting of Stock Option and Stock Awards Granted in Fiscal Year tha tVested During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [3]     643,291    
Dennis Polk [Member] | Change in Fair Value as of Vesting Date of Stock Option and Stock Awards Granted in Prior Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [3],[10]     2,269,314    
Dennis Polk [Member] | Fair Value as of Prior Fiscal Year-End of Stock Option and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [3],[10]     0    
Non-PEO NEO | Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [9] $ (1,114,461) (1,264,076) (2,716,425) [3]    
Non-PEO NEO | Fair Value at Fiscal Year-End of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] 1,086,993 1,344,275 4,132,599 [3]    
Non-PEO NEO | Change in Fair Value of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] (301,906) (110,432) 375,500 [3]    
Non-PEO NEO | Fair Value at Vesting of Stock Option and Stock Awards Granted in Fiscal Year tha tVested During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 187,951 [3]    
Non-PEO NEO | Change in Fair Value as of Vesting Date of Stock Option and Stock Awards Granted in Prior Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] 38,354 (181,782) 761,446 [3]    
Non-PEO NEO | Fair Value as of Prior Fiscal Year-End of Stock Option and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount [10] $ 0 $ 0 $ 0 [3]    
[1] Amounts reflect the table labeled “2023 Summary Compensation Table” for our NEOs for each corresponding year, as follows:
(i)    the total compensation reported in the 2023 Summary Compensation Table for the applicable year for PEO 1 and PEO 2, and
(ii)    the average of the total compensation reported in the 2023 Summary Compensation Table for the applicable year for the Non-PEO NEOs reported for the applicable year.
[2] Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year for the PEOs. For Non-PEO NEOs, amounts shown represent averages.
[3] On December 1, 2020, the Company completed the separation (the “Separation”) of its customer experience services business in a tax-free transaction for federal income tax purposes, which was accomplished by the distribution of one hundred percent of the outstanding common stock of Concentrix Corporation (“Concentrix”). SYNNEX stockholders received one share of Concentrix common stock for every share of SYNNEX common stock held at the close of business on the record date. Concentrix is now an independent public company trading under the symbol “CNXC” on the Nasdaq Stock Market. After the Separation, SYNNEX did not beneficially own any shares of Concentrix’ common stock. The closing stock price of SYNNEX common stock on November 30, 2020 was $160.31. As a result of the impacts of the Separation, the opening stock price of SYNNEX common stock on December 1, 2020 was $82.01. The Company has used the opening stock price on December 1, 2020 to calculate changes in fair value of equity awards in fiscal 2021 in order to provide a comparable basis of performance for the fair value measurements.
[4] The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table above for each year, adjusted for exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values in the Summary Compensation Table are calculated in accordance with FASB ASC Topic 718, using the grant date fair value of stock and option awards granted during the year, whereas CAP represents the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or were vested or forfeited during the year.
 Year
Summary Compensation Table Total(a)
($)
(Minus) Grant Date Fair Value of Stock Option and Stock Awards Granted in Fiscal Year(b)
($)
Plus Fair Value at Fiscal Year-End of Outstanding and Unvested Stock Option and Stock Awards Granted in Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value of Outstanding and Unvested Stock Option and Stock Awards Granted in Prior Fiscal Years(c)
($)
Plus Fair Value at Vesting of Stock Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year(c)
($)
Plus/(Minus) Change in Fair Value as of Vesting Date of Stock Option and Stock Awards Granted in Prior Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year(c)
($)
(Minus) Fair Value as of Prior Fiscal Year-End of Stock Option and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year(c)
($)
 Equals Compensation Actually Paid
($)
PEO 1
20239,254,634 (5,759,614)5,677,045 (701,565)— (277,226)— 8,193,274 
20227,498,195 (4,349,941)5,409,421 11,252 — (112,159)— 8,456,768 
2021(d)
9,529,362 (3,639,900)3,445,153 — — — — 9,334,615 
PEO 2
2023 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2022 n/a  n/a  n/a  n/a  n/a  n/a  n/a  n/a
2021(d)
16,704,037 (12,528,928)14,611,088 1,574,513 643,291 2,269,314 — 23,273,315 
Non-PEO NEOs (Average)
20232,817,204 (1,114,461)1,086,993 (301,906)— 38,354 — 2,526,184 
20223,121,580 (1,264,076)1,344,275 (110,432)— (181,782)— 2,909,564 
2021(d)
4,709,006 (2,716,425)4,132,599 375,500 187,951 761,446 — 7,450,077 
(a)    Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year for the PEOs. For Non-PEO NEOs, amounts shown represent averages.
(b)    Represents the grant date fair value of the stock options and stock awards granted during the indicated fiscal year, calculated in accordance with ASC 718 as reported on the Summary Compensation Table. See Note 5 “Share-Based Compensation” to the Audited Financial Statements included in our Form 10-K for the fiscal year ended November 30, 2023 for a discussion of the relevant assumptions used in calculating these amounts.
(c)    The fair values of unvested and outstanding equity awards to our NEOs were remeasured starting on November 30, 2020, and subsequently as of each vesting date of vested awards, and as of the end of each fiscal year for unvested awards during the indicated fiscal year. Fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value on the grant date under US GAAP. For stock awards subject to performance-based vesting conditions, fair value was calculated based on an estimate of the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year. For stock options, a Black-Scholes model was used to estimate the fair value as of the various measurement dates based on the same methodology as used to determine grant date fair value but using the closing stock price on the applicable revaluation date, as well as updated assumptions related to the expected term, expected volatility, risk-free interest rate and dividend yield.
(d)     On December 1, 2020, the Company completed the separation (the “Separation”) of its customer experience services business in a tax-free transaction for federal income tax purposes, which was accomplished by the distribution of one hundred percent of the outstanding common stock of Concentrix Corporation (“Concentrix”). SYNNEX stockholders received one share of Concentrix common stock for every share of SYNNEX common stock held at the close of business on the record date. Concentrix is now an independent public company trading under the symbol “CNXC” on the Nasdaq Stock Market. After the Separation, SYNNEX did not beneficially own any shares of Concentrix’ common stock. The closing stock price of SYNNEX common stock on November 30, 2020 was $160.31. As a result of the impacts of the Separation, the opening stock price of SYNNEX common stock on December 1, 2020 was $82.01. The Company has used the opening stock price on December 1, 2020 to calculate changes in fair value of equity awards in fiscal 2021 in order to provide a comparable basis of performance for the fair value measurements.
[5] Cumulative total shareholder return (“TSR”) assumes an initial investment of $100 as of the market open on December 1, 2020, the beginning of fiscal year 2021, for the Company’s common stock as well as the common stock of companies in our peer group. Our peer group is measured by the Computer and Peripheral Equipment index, which is based on the Standard Industrial Classification Code 5045—Wholesale Computer and Computer Peripheral Equipment and Software. For 2021, the measurement period was one (1) year, for 2022, the measurement period was two (2) years, and for 2023, the measurement period was three (3) years.
[6] Reflects “Net Income” in our consolidated statements of income included in our Annual Reports on Form 10-K for the applicable year.
[7] While we use numerous financial and non-financial performance measures to evaluate performance under our compensation programs, non-GAAP net income is our Company Selected Measure, which is the financial performance measure that, in our assessment, represents the most important performance measure used to link CAP to NEOs to Company performance in 2023. For a reconciliation of non-GAAP net income to the most directly comparable GAAP financial measure, net income, refer to Appendix A of this Proxy Statement for the reconciliation of GAAP to non-GAAP net income.
[8] Non-GAAP net income is a non-GAAP financial measure, which is considered to be the most important measure used by the Company to link compensation actually paid to our PEO and the average of Non-PEO NEOs to Company performance, also known as our Company Selected Measure. For a reconciliation of non-GAAP net income to the most directly comparable GAAP financial measure, net income, refer to Appendix A to this Proxy Statement.
[9] Represents the grant date fair value of the stock options and stock awards granted during the indicated fiscal year, calculated in accordance with ASC 718 as reported on the Summary Compensation Table. See Note 5 “Share-Based Compensation” to the Audited Financial Statements included in our Form 10-K for the fiscal year ended November 30, 2023 for a discussion of the relevant assumptions used in calculating these amounts.
[10] The fair values of unvested and outstanding equity awards to our NEOs were remeasured starting on November 30, 2020, and subsequently as of each vesting date of vested awards, and as of the end of each fiscal year for unvested awards during the indicated fiscal year. Fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value on the grant date under US GAAP. For stock awards subject to performance-based vesting conditions, fair value was calculated based on an estimate of the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year. For stock options, a Black-Scholes model was used to estimate the fair value as of the various measurement dates based on the same methodology as used to determine grant date fair value but using the closing stock price on the applicable revaluation date, as well as updated assumptions related to the expected term, expected volatility, risk-free interest rate and dividend yield.